{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:50:36Z","timestamp":1790481036088,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.tmaid.2006.09.004","type":"journal-article","created":{"date-parts":[[2006,11,2]],"date-time":"2006-11-02T11:40:16Z","timestamp":1162467616000},"page":"150-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":173,"title":["Cutaneous leishmaniasis treatment"],"prefix":"10.1016","volume":"5","author":[{"given":"Philippe","family":"Minodier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Parola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2006.09.004_bib1","series-title":"Les leishmanioses","first-page":"173","article-title":"Leishmanioses t\u00e9gumentaires","author":"Dedet","year":"1999"},{"key":"10.1016\/j.tmaid.2006.09.004_bib2","series-title":"Les leishmanioses","first-page":"131","article-title":"Epid\u00e9miologie des leishmanioses de l\u2019Ancien Monde","author":"Ashford","year":"1999"},{"key":"10.1016\/j.tmaid.2006.09.004_bib3","series-title":"Les leishmanioses","first-page":"147","article-title":"Epid\u00e9miologie des leishmanioses du Nouveau Monde","author":"Dedet","year":"1999"},{"key":"10.1016\/j.tmaid.2006.09.004_bib4","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2006.09.004_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","article-title":"Treatment of cutaneous leishmaniasis among travellers","volume":"53","author":"Blum","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tmaid.2006.09.004_bib6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(05)70296-6","article-title":"Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980\u20132004","volume":"5","author":"Olliaro","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tmaid.2006.09.004_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijantimicag.2004.09.011","article-title":"Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?","volume":"25","author":"Kafetzis","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tmaid.2006.09.004_bib8","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.arcped.2005.01.009","article-title":"First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France","volume":"12","author":"Minodier","year":"2005","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.tmaid.2006.09.004_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1472-8206.2003.00168.x","article-title":"Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients","volume":"17","author":"Minodier","year":"2003","journal-title":"Fund Clin Pharmacol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib10","unstructured":"World Health Organization. The leishmaniases. WHO technical report series, vol. 701. Geneva: WHO; 1984."},{"key":"10.1016\/j.tmaid.2006.09.004_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0738-081X(99)00049-8","article-title":"Treatment of cutaneous leishmaniasis: retrospectives and advances for the 21st century","volume":"17","author":"Moskowitz","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D30X40S44G","article-title":"Chilhood leishmaniasis: report of 106 cases","volume":"10","author":"Kharfi","year":"2004","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.tmaid.2006.09.004_bib13","first-page":"1255","article-title":"Formes clinico-\u00e9pid\u00e9miologiques des leishmanioses cutan\u00e9es en Tunisie","volume":"115","author":"Chaffai","year":"1998","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.medmal.2005.11.018","article-title":"Adverse effects of intralesional Glucantime\u00ae in the treatment of cutaneous leishmaniosis","volume":"36","author":"Masmoudi","year":"2006","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.tmaid.2006.09.004_bib15","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/00034983.1997.11813217","article-title":"Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration","volume":"91","author":"Alkhawajah","year":"1997","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0001-706X(02)00134-1","article-title":"Leishmaniasis in Turkey","volume":"84","author":"Ok","year":"2002","journal-title":"Acta Trop"},{"key":"10.1016\/j.tmaid.2006.09.004_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2133.1999.02673.x","article-title":"Cutaneous leishmaniasis: evaluation of 3074 cases in the Cukurova region of Turkey","volume":"140","author":"Uzun","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1645\/GE-185R","article-title":"Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey","volume":"90","author":"Uzun","year":"2004","journal-title":"J Parasitol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.0011-9059.2001.01396.x","article-title":"Cutaneous leishmaniasis in Sanliurfa: epidemiologic and clinical features of the last four years (1997\u20132000)","volume":"41","author":"Gurel","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib20","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1346-8138.1995.tb03911.x","article-title":"A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution","volume":"22","author":"Sharquie","year":"1995","journal-title":"J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2230.1997.tb01054.x","article-title":"A comparative controlled trial of intralesionally administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute leishmaniasis","volume":"22","author":"Sharquie","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2006.09.004_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0190-9622(92)70175-F","article-title":"Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study","volume":"27","author":"El-On","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib24","first-page":"353","article-title":"Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran","volume":"81","author":"Asilian","year":"2003","journal-title":"Bull WHO"},{"key":"10.1016\/j.tmaid.2006.09.004_bib25","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1365-4632.2004.02597.x","article-title":"Comparing the efficiency of topical paromomycine with intralesional meglumine antimoniate for cutaneous leishmaniasis","volume":"44","author":"Moosavi","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-4362.1997.00022.x","article-title":"A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey","volume":"36","author":"Ozgoztasi","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2230.2003.01169.x","article-title":"Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate","volume":"28","author":"Faghihi","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0020-7519(93)90104-7","article-title":"Topical treatment of cutaneous leishmaniasis in Belize: in vitro and in vivo studies with Leishmania mexicana","volume":"23","author":"El-On","year":"1993","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0190-9622(93)70209-C","article-title":"Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study","volume":"29","author":"Weinrauch","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib30","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala","volume":"65","author":"Arana","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0035-9203(97)90290-X","article-title":"Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin","volume":"91","author":"Neva","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","article-title":"Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis","volume":"91","author":"Armijos","year":"2004","journal-title":"Acta Trop"},{"key":"10.1016\/j.tmaid.2006.09.004_bib33","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"Buates","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2006.09.004_bib34","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1086\/324161","article-title":"Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator","volume":"33","author":"Arevalo","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2006.09.004_bib35","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/429238","article-title":"Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru","volume":"40","author":"Miranda-Verastegui","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2006.09.004_bib36","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1365-4362.2003.01955.x","article-title":"Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod","volume":"42","author":"Seeberger","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib37","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0035-9203(01)90158-0","article-title":"Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B","volume":"95","author":"Vardy","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/01.inf.0000069794.83612.2f","article-title":"Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B","volume":"22","author":"Zvulunov","year":"2003","journal-title":"Pediatr Inf Dis J"},{"key":"10.1016\/j.tmaid.2006.09.004_bib39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-4632.2005.02628.x","article-title":"Treatment of cutaneous leishmaniasis with cryosurgery","volume":"44","author":"Panagiotopoulos","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib40","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1365-4362.1997.00045.x","article-title":"2-year study of liquid nitrogen therapy in cutaneous leishmaniasis","volume":"36","author":"Al-Majali","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","article-title":"Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime\u00ae) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime\u00ae) alone for the treatment of cutaneous leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1179\/000349803225001373","article-title":"The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis","volume":"97","author":"Asilian","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.1990.42.43","article-title":"Placebo-controlled clinical trial of meglumine antimonite (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala","volume":"42","author":"Navin","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4269\/ajtmh.1997.57.309","article-title":"Treatment of cutaneous leishmaniasis with localized current field (radio frequency) in Tabasco, Mexico","volume":"57","author":"Velasco-Castrejon","year":"1997","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib45","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jaad.2005.01.109","article-title":"Cutaneous leishmaniasis in soldiers from Fort Campbell, Kentucky returning from Op\u00e9ration Iraqi Freedom highlights diagnostic and therapeutic options","volume":"52","author":"Willard","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib46","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/428736","article-title":"Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial","volume":"40","author":"Reithinger","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2006.09.004_bib47","first-page":"103","article-title":"Treatment of cutaneous leishmaniasis using a carbon dioxide laser","volume":"69","author":"Babajev","year":"1991","journal-title":"Bull WHO"},{"key":"10.1016\/j.tmaid.2006.09.004_bib48","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-4632.2004.02349.x","article-title":"Evaluation of CO laser efficacy in the treatment of cutaneous leishmaniasis","volume":"43","author":"Asilian","year":"2004","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.tmaid.2006.09.004_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D35ZB4V6KF","article-title":"Carbon dioxide laser for the treatment of lupoid cutaneous leishmaniasis (LCL): a case series of 24 patients","volume":"12","author":"Asilian","year":"2006","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.tmaid.2006.09.004_bib50","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/archderm.139.4.432","article-title":"Treatment of cutaneous leishmaniasis with photodynamic therapy","volume":"139","author":"Enk","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1699-0463.1988.tb05342.x","article-title":"An experimental model system for leishmaniasis. Effects of porphyrin-compounds and menadione on Leishmania parasites engulfed by cultured macrophages","volume":"96","author":"Abok","year":"1988","journal-title":"APMIS"},{"key":"10.1016\/j.tmaid.2006.09.004_bib52","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1067\/mjd.2003.218","article-title":"Treatment of cutaneous leishmaniasis by photodynamic therapy","volume":"48","author":"Gardlo","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib53","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/j.jaad.2003.10.676","article-title":"Treatment of cutaneous leishmaniasis by photodynamic therapy","volume":"50","author":"El-On","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","article-title":"Efficacy of ketoconazole against Leishmania braziliensis pananamensis cutaneous leishmaniasis","volume":"89","author":"Saenz","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.tmaid.2006.09.004_bib55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","article-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","volume":"165","author":"Navin","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2006.09.004_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/09546630152607899","article-title":"Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis","volume":"12","author":"Salmanpour","year":"2001","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.tmaid.2006.09.004_bib57","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major","volume":"346","author":"Alrajhi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2006.09.004_bib58","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1001\/archderm.138.12.1604","article-title":"Fluconazole for cutaneous leishmaniasis: looking for a better treatment","volume":"138","author":"Gonzalez","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib59","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2230.2004.01561.x","article-title":"Cutaneous leishmaniasis in a Kosovan child treated with oral fluconazole","volume":"29","author":"Baron","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib60","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0020-7519(96)00128-2","article-title":"Itraconazole and leishmaniasis: a randomised double-blind trial in cutaneous disease","volume":"26","author":"Dogra","year":"1996","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1201-9712(00)90077-8","article-title":"Use of itraconazole in the treatment of mucocutaneous leishmaniasis: a pilot study","volume":"4","author":"Amato","year":"2000","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.tmaid.2006.09.004_bib62","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-4632.2004.02429.x","article-title":"Cutaneous leishmaniasis: successful treatment with itraconazole","volume":"45","author":"Consigli","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib63","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2310\/7060.2004.19109","article-title":"Itraconazole can be effective in the treatment of sporotrichoid leishmaniasis","volume":"11","author":"Morelli","year":"2004","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2006.09.004_bib64","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1525-1470.2006.00177.x","article-title":"Cutaneous leishmaniasis: three children with Leishmania major successfully treated with itraconazole","volume":"23","author":"White","year":"2006","journal-title":"Pediat Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib65","first-page":"784","article-title":"Treatment of cutaneous leishmaniasis with itraconazole","volume":"132","author":"Momeni","year":"1996","journal-title":"Randomized double-blind study. Arch Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib66","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1468-3083.2004.01133.x","article-title":"A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis","volume":"19","author":"Nassiri-Kashani","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib67","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-4632.2004.02183.x","article-title":"Itraconazole in the treatment of New World mucocutaneous leishmaniasis","volume":"43","author":"Calvopina","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib68","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4269\/ajtmh.2002.67.273","article-title":"Activity of azithromycine against Leishmania major in vitro and in vivo","volume":"67","author":"Krolewiecki","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1590\/S0037-86822003000100010","article-title":"Efficacy of azithromycin in the treatment of cutaneous leishmaniasis","volume":"36","author":"Prata","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.tmaid.2006.09.004_bib70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1590\/S0036-46652004000300011","article-title":"Case report: azithromycine in the treatment of mucosal leishmaniasis","volume":"46","author":"Silva-Vergara","year":"2004","journal-title":"Rev Inst Med Trop S Paulo"},{"key":"10.1016\/j.tmaid.2006.09.004_bib71","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/380638","article-title":"Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India","volume":"38","author":"Bhattacharya","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2006.09.004_bib72","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2006.09.004_bib73","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for New World cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2006.09.004_bib74","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1086\/430444","article-title":"Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1","volume":"40","author":"Schraner","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2006.09.004_bib75","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH3 (edelfosine) and amphotericin B","volume":"81","author":"Escobar","year":"2002","journal-title":"Acta Trop"},{"key":"10.1016\/j.tmaid.2006.09.004_bib76","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4269\/ajtmh.2005.73.272","article-title":"The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine","volume":"73","author":"Yardley","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib77","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1590\/S0074-02761998000600025","article-title":"Zinc sulphate in the treatment of cutaneous leishmaniasis: an in vitro and animal study","volume":"93","author":"Najim","year":"1998","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.tmaid.2006.09.004_bib78","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2230.2001.00752.x","article-title":"Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis","volume":"26","author":"Sharquie","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib79","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4269\/ajtmh.2001.64.187","article-title":"Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimoniate for cutaneous leishmaniasis due to Leishmania Viannia species","volume":"64","author":"Palacios","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1590\/S0037-86822005000300001","article-title":"retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimoniate","volume":"38","author":"Schubach","year":"2005","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.tmaid.2006.09.004_bib81","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2001.65.456","article-title":"Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate","volume":"65","author":"Romero","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib82","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0035-9203(81)90198-X","article-title":"Allopurinol in the treatment of visceral leishmaniasis","volume":"75","author":"Kager","year":"1981","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib83","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0035-9203(83)90071-8","article-title":"Evaluation of allopurinol in the treatment of kala-azar occurring in North Bihar, India","volume":"77","author":"Jha","year":"1983","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib84","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0035-9203(85)90200-7","article-title":"Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol","volume":"79","author":"Chunge","year":"1985","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib85","first-page":"611","article-title":"Treatment of visceral leishmaniasis with meglumine and allopurinol","volume":"147","author":"Ragusa","year":"1993","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.tmaid.2006.09.004_bib86","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-4362.2002.01527.x","article-title":"Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate","volume":"41","author":"Momeni","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib87","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-4362.2002.01526.x","article-title":"Evaluating the efficacy of allopurinol and meglumine antimoniate (Glcantime) in the treatment of cutaneous leishmaniasis","volume":"41","author":"Esfandiarpour","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib88","first-page":"40","article-title":"Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol","volume":"13","author":"Momeni","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib89","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-4362.2003.01868.x","article-title":"American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline","volume":"42","author":"Bafica","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4269\/ajtmh.2001.65.87","article-title":"Successful treatment of refractory leishmaniasis with pentoxifylline plus antimony","volume":"65","author":"Lessa","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib91","first-page":"33","article-title":"Pathophysiology of Mediterranean visceral leishmaniasis","volume":"28","author":"Minodier","year":"1999","journal-title":"Presse Med"},{"key":"10.1016\/j.tmaid.2006.09.004_bib92","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00006454-199808000-00008","article-title":"Pediatric visceral leishmaniasis in southern France","volume":"17","author":"Minodier","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tmaid.2006.09.004_bib93","first-page":"35","article-title":"Th\u00e9rapeutique des leishmanioses t\u00e9gumentaires du Nouveau Monde. Exp\u00e9rience \u00e0 propos de 326 cas trait\u00e9s par isethionate de pentamidine \u00e0 fortes doses","volume":"63","author":"Lightburn","year":"2003","journal-title":"Med Trop"},{"key":"10.1016\/j.tmaid.2006.09.004_bib94","first-page":"365","article-title":"A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20mgSbV\/day for 20 days to treat cutaneous leishmaniasis","volume":"36","author":"De Paula","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.tmaid.2006.09.004_bib95","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2005.72.133","article-title":"Comparison of meglumine natimoniate and pentamidine for Peruvian cutaneous leishmaniasis","volume":"72","author":"Andersen","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib96","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.actatropica.2004.06.006","article-title":"Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients","volume":"92","author":"Amato","year":"2004","journal-title":"Acta Trop"},{"key":"10.1016\/j.tmaid.2006.09.004_bib97","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2133.2005.06670.x","article-title":"Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis","volume":"153","author":"Brown","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib98","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/j.jinf.2005.03.012","article-title":"Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B","volume":"51","author":"Paradisi","year":"2005","journal-title":"J Infect"},{"key":"10.1016\/j.tmaid.2006.09.004_bib99","first-page":"209","article-title":"Traitement par amphot\u00e9ricine B liposomale d\u2019une leishmaniose cutan\u00e9e contract\u00e9e \u00e0 Djibouti et r\u00e9sistante \u00e0 l\u2019antimoniate de m\u00e9glumine","volume":"96","author":"Rapp","year":"2003","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1016\/j.tmaid.2006.09.004_bib100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0924-8579(99)00133-8","article-title":"A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis","volume":"13","author":"Yardley","year":"2000","journal-title":"Int J Antimicrobiol Agents"},{"key":"10.1016\/j.tmaid.2006.09.004_bib101","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis","volume":"21","author":"Croft","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.tmaid.2006.09.004_bib102","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4269\/ajtmh.2001.65.685","article-title":"Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi","volume":"65","author":"Dietze","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2006.09.004_bib103","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1128\/AAC.49.12.4950-4956.2005","article-title":"Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases","volume":"49","author":"Nakayama","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmaid.2006.09.004_bib104","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/319366","article-title":"Guide to development of practice guidelines","volume":"32","author":"Kish","year":"2001","journal-title":"Clin Infect Dis"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893906001025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893906001025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:56:17Z","timestamp":1761486977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893906001025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S1477893906001025"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2006.09.004","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous leishmaniasis treatment","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2006.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}